IP Library › Granted Patent US 5,859,047
Granted Patent Utility
US 5,859,047 · App. 08/866,798

Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors

Inventors: Harold C. Kluender, David R. Brittelli, William Bullock, Kerry Combs, Brian R. Dixon, Michael C. VanZandt, Scott Wilhelm, Donald J. Wolanin
Patented Case View Patent ↗
Granted: Jan 12, 1999 Filed: May 30, 1997
Inventors
Harold C. Kluender
David R. Brittelli
William Bullock
Kerry Combs
Brian R. Dixon
Michael C. VanZandt
Scott Wilhelm
Donald J. Wolanin
Assignee (at issue)
Bayer Aktiengesellschaft

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 5,859,047
App. No.
08/866,798
Filed
1997-05-30
Granted
1999-01-12
Kind
A